Lithium inhibits the reverse tolerance and the c-Fos expression induced by methamphetamine in mice

Brain Research

Volumn 782, Issue 1-2, 1998, Pages 83-90

  Namima, Misako ^a   Sugihara, Katsunobu ^a   Okamoto, Koichi ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Activity; Ambulatory; C Fos protein; Geniculate nucleus; Lithium; Methamphetamine; Reverse tolerance; Striatum

Indexed keywords

LITHIUM; METHAMPHETAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG INHIBITION; DRUG TOLERANCE; GENE EXPRESSION; HYPERKINESIA; IMMEDIATE EARLY GENE; LATERAL GENICULATE BODY; MALE; MOUSE; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; CORPUS STRIATUM; DRUG COMBINATIONS; DRUG TOLERANCE; GENICULATE BODIES; INJECTIONS; LITHIUM; MALE; METHAMPHETAMINE; MICE; MICE, INBRED STRAINS; MOTOR ACTIVITY; PROTO-ONCOGENE PROTEINS C-FOS; TIME FACTORS;

EID: 0032567688     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)01270-5     Document Type: Article

References (56)

1. Baptista T.J., Hernandez L., Burguera J.L., Burguera M., Hoebel B.G. Chronic lithium administration enhances serotonin release in the lateral hypothalamus but not in the hippocampus in rats. A microdialysis study. J. Neural. Transmission - Gen. Sec. 82:1990;31-41.
2. Baptista T., Teneud L., Contreras Q., Burguera J.L., Burguera M., Hernandez L. Effects of acute and chronic lithium treatment on amphetamine-induced dopamine increase in the nucleus accumbens and prefrontal cortex in rats as studied by microdialysis. J. Neural. Transmission - Gen. Sec. 94:1993;75-89.
3. Berggren U. Effects of chronic lithium treatment on brain monoamine metabolism and amphetamine-induced locomotor stimulation in rats. J. Neural. Transmission. 64:1985;239-250.
4. Berggren U., Engel J., Liljequist S. The effect of lithium on the locomotor stimulation induced by dependence-producing drugs. J. Neural. Transmission. 50:1981;157-164.
5. Berggren U., Tallstedt L., Ahlenius S., Engel J. The effect of lithium on amphetamine-induced locomotor stimulation. Psychopharmacology. 59:1978;41-45.
6. Borison R.L., Sabelli H.C., Maple P.J., Havdala H.S., Diamond B.I. Lithium prevention of amphetamine-induced 'manic' excitement and of reserpine-induced 'depression' in mice: possible role of 2-phenylethyl-amine. Psychopharmacology. 59:1978;259-262.
7. Buchsbaum M.S., van Kammen D.P., Murphy D.L. Individual differences in average evoked responses to D- and L-amphetamine with and without lithium carbonate in depressed patients. Psychopharmacology. 51:1977;129-135.
8. Cade J.F.J. Lithium salt in the treatment of psychotic excitement. Med. J. Australia. 2:1949;349-352.
9. Cappeliez P., Moore E. Effects of lithium on an amphetamine animal model of bipolar disorder. Progr. Neuro-Psychopharmacol. Biol. Psychiatry. 14:1990;347-358.
10. Carney J.M., Tolliver B., Carney J.P., Kindy M.S. Selective effects of behaviorally active doses of methamphetamine on mRNA expression in the gerbil brain. Neuropharmacology. 30:1991;1011-1019.
11. Chaudhry I.A., Turkanis S.A., Karler R. Characteristics of 'reverse tolerance' to amphetamine-induced locomotor stimulation in mice. Neuropharmacology. 27:1988;777-781.
12. Ebstein R.P., Eliashar S., Belmaker R.H., Ben-Uriah Y., Yehuda S. Chronic lithium treatment and dopamine-mediated behavior. Biol. Psychiatry. 15:1980;459-467.
13. Engel J., Berggren U. Effects of lithium on behaviour and central monoamines. Acta. Psychiatr. Scand. Suppl. 280:1980;133-143.
14. Fessler R.G., Sturgeon R.D., London S.F., Meltzer H.Y. Effects of lithium on behaviour induced by phencyclidine and amphetamine in rats. Psychopharmacology. 78:1982;373-376.
15. Flemenbaum A. Lithium inhibition of norepinephrine and dopamine receptors. Biol. Psychiatry. 12:1977;563-572.
16. Furukawa T., Ushijima I., Ono N. Modifications by lithium of behavioral responses to methamphetamine and tetrabenazine. Psychopharmacologia. 42:1975;243-248.
17. Graybiel A.M., Moratalla R., Robertson H.A. Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc. Natl. Acad. Sci. USA. 87:1990;6912-6916.
18. Hamada K., Maeda H., Tominaga H., Takigawa M. Effects of lithium salt on intracranial self-stimulation and methaphetamine-induced hyperactivity in rats. Psychiatria et Neurologia Japonica. 85:1983;215-225.
19. Hamburger-Bar R., Robert M., Newman M., Belmaker R.H. Interstrain correlation between behavioural effects of lithium and effects on cortical cAMP. Pharmacol. Biochem. Behav. 24:1986;9-13.
20. Hayashi T., Hirabayashi M., Tadokoro S. Strain differences in the reverse tolerance to methamphetamine and changes in catecholaminergic neurons in mice. Jpn. J. Pharmacol. 44:1987;259-267.
21. Hayashi T., Kuribara M., Tadokoro S. Enhancement of ambulation-increasing effect produced by repeated administration of methamphetamine in rats and neurochemical changes in catecholaminergic neurons. Jpn. J. Pharmacol. 43:1987;283-290.
22. Hirabayashi M., Okada S., Tadokoro S. Comparison of sensitization to ambulation-increasing effects of cocaine and methamphetamine after repeated administration in mice. J. Pharm. Pharmacol. 43:1991;827-830.
23. Hirabayashi M., Tadokoro S. Effect of chlorpromazine on mouse ambulatory activity sensitization caused by (+)-amphetamine. J. Pharm. Pharmacol. 45:1993;481-483.
24. Hope B.T., Nye H.E., Kelz M.B., Self D.W., Iadarola M.J., Nakabeppu Y., Duman R.S., Nestler E.J. Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments. Neuron. 13:1994;1235-1244.
25. Johansson B., Lindstrom K., Fredholm B.B. Differences in the regional and cellular localization of c-fos messenger RNA induced by amphetamine, cocaine and caffeine in the rat. Neuroscience. 59:1994;837-849.
26. Kaneno S., Watanabe A., Takahashi R. Alteration of striatal dopaminergic functions implicated in methamphetamine-induced reverse tolerance in rats. Eur. J. Pharmacol. 123:1986;287-294.
27. Kifune A., Tadokoro S. Modification of stereotypy-producing and ambulation-increasing effects following repeated administration of methamphetamine in rats. Jpn. J. Psychopharmacol. 11:1991;207-214.
28. Kuczenski R., Leith N.J. Chronic amphetamine: is dopamine a link in or a mediator of the development of tolerance and reverse tolerance? Pharmacol. Biochem. Behav. 15:1981;405-413.
29. Kuribara H., Tadokoro S. Reverse tolerance to ambulation-increasing effects of methamphetamine and morphine in 6 mouse strain. Jpn. J. Pharmacol. 49:1989;197-203.
30. Kuribara H., Tadokoro S. Effects of YM-09151-2, a potent and selective dopamine D2 antagonist, on the ambulation-increasing effect of methamphetamine in mice. Jpn. J. Pharmacol. 52:1990;489-492.
31. Leith N.J., Kuczenski R. Chronic amphetamine: tolerance and reverse tolerance reflect different behavioral actions of the dog. Pharmacol. Biochem. Behav. 15:1981;399-405.
32. Liu J., Nickolenko J., Sharp F.R. Morphine induces c-fos and jun B in striatum and nucleus accumbens via D1 and N-methyl-D-aspartate receptors. Proc. Natl. Acad. Sci. USA. 91:1994;8537-8541.
33. Merchant K.M., Hanson G.R., Dorsa D.M. Induction of neurotensin and c-fos mRNA in distinct subregions of rat neostriatum after acute methamphetamine: comparison with acute haloperidol effects. J. Pharmacol. Exp. Ther. 269:1994;806-812.
34. Miyauchi T., Kikuchi K., Satoh S. Further studies on the potentiating effect of lithium chloride on methamphetamine-induced stereotypy in mice. Jpn. J. Pharmacol. 31:1981;61-68.
35. Nguyen T.V., Kosofsky B.E., Birnbaum R., Cohen B.M., Hyman S.E. Differential expression of c-Fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine. Proc. Natl. Acad. Sci. USA. 89:1992;4270-4274.
36. Nozu T., Furukawa T. Effects of lithium chloride administered in combination with methamphetamine or a reserpine-like drugs on brain norepinephrine and dopamine metabolism in rats. Folia. Pharmacologica. Japonica. 72:1976;715-723.
37. Ohno M., Yoshida H., Watanabe S. NMDA receptor-mediated expression of Fos protein in the rat striatum following methamphetamine administration: relation to behavioral sensitization. Brain Res. 665:1994;135-140.
38. Okubo Y., Suhara T., Suzuki K., Kobayashi K., Inoue O., Terasaki O., Someya Y., Sassa T., Sudo Y., Matsushima E., Iyo M., Tateno Y., Toru M. Decreased profrontal dopamine D1 receptors in schizophrenia revealed by PET. Nature. 385:1990;634-636.
39. Ozawa H., Miyauchi T. Potentiating effect of lithium chloride on methamphetamine-induced stereotypy in mice. Eur. J. Pharmacol. 41:1977;213-216.
40. Ozawa H., Nozu T., Aihara H., Akiyama F., Sasajima M. Pharmacokinetics and general pharmacological actions of lithium salts administered singly or repeatedly. Folia. Pharmacologica. Japonica. 72:1976;433-443.
41. Pittman K.J., Jakuvovic A., Fibiger H.C. The effects of chronic lithium on behavioral and biochemical indices of dopamine receptor supersensitivity in the rat. Psychopharmacology. 82:1984;371-377.
42. Poncelet M., Dangoumau L., Soubrie P., Simon P. Effects of neuroleptic drugs, clonidine and lithium on the expression of conditioned behavioral excitation in rats. Psychopharmacology. 92:1987;393-397.
43. Rubin E.H., Wooten G.F. The behavioral and biochemical effects of lithium on dopaminergic agonist-induced supersensitivity. Psychopharmacology. 84:1984;217-220.
44. Ruskin D.N., Marshall J.F. Amphetamine- and cocaine-induced Fos in the rat striatum depends on D2 dopamine receptor activation. Synapse. 18:1994;233-240.
45. Schou M. Lithium in psychiatric therapy and prophylaxis. J. Psychiatr. Res. 6:1968;67-95.
46. Segal D.S., Callaghan M., Mandell A.J. Alteration in behavior and catecholamine biosynthesis induced by lithium. Nature. 254:1975;58-59.
47. S. Shiosaka, M. Tohyama, Immunohistochemical techniques. In P.C. Emson and M. Tohyama (Eds.), Progress Brain Research, Vol. 66, Elsevier, Amsterdam, 1986, pp. 3-32.
48. Smith D.F. Central and peripheral effects of lithium on amphetamine-induced hyperactivity in rats. Pharmacol. Biochem., Behav. 14:1981;439-442.
49. Tadokoro S., Kuribara H. Reverse tolerance to the ambulation-increasing effect of methamphetamine in mice as an animal model of amphetamine-psychosis. Psychopharmacol. Bull. 22:1986;757-762.
50. Tadokoro S., Kuribara H. Modification of the behavioral effects of drugs after repeated administration: special reference to the reverse tolerance. Folia. Pharmacologica. Japonica. 95:1990;229-238.
51. Takigawa M., Maeda H., Ueyama K., Tominaga H., Matsumoto K. A dual approach to self-stimulation and locomotor trace affected by chronic methamphetamine treatment for an animal model of schizophrenia. Can. J. Physiol. Pharmacol. 71:1993;321-325.
52. Ushijima I., Yamada K., Furukawa T. Behavioral effects of lithium on presynaptic sites of catecholaminergic neurons in the mouse. Arch. Intern. Pharmacodynamie. et de Therapie. 282:1986;58-67.
53. van Kammen D.P., Docherty J.P., Marder S.R., Rosenblatt J.E., Bunney Jr W.E. Lithium attenuates the activation-euphoria but not the psychosis induced by D-amphetamine in schizophrenia. Psychopharmacology. 87:1985;111-115.
54. van Kammen D.P., Murphy D.L. Attenuation of the euphoriant and activating effects of D- and L-amphetamine by lithium carbonate treatment. Psychopharmacologia. 44:1975;215-224.
55. van Kammen D.P., Murphy D.L. Prediction of antidepressant response to lithium carbonate by a 1-day administration of D-amphetamine in unipolar depressed women. Neuropsychobiology. 5:1979;266-273.
56. Williams G.V., Goldman-Pakic P.S. Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature. 376:1995;572-575.